FDA eases rules on digital mammography devices

Nov 3, 2010

The U.S. Food and Drug Administration has downgraded the classification of full-field digital mammography devices from high risk to medium risk, making it easier for companies to bring the technology to market, the agency announced today.

Click here to read the rest of the article.

Latest in Breast
Dcis Thumbnail
MRI radiomics model predicts risk in women with DCIS
April 1, 2025
Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.
Do radiologists trust mammography AI software?
March 18, 2025
Breast Mammo 400
Mammographic breast density not affected by multivitamins
March 17, 2025
Fes Pet2 Thumbnail
FES-PET shows promise staging patients with low-grade breast cancer
March 4, 2025
Related Stories
2010 08 19 12 35 41 749 Destounis thumb 08 10 Sm
Breast
Breast CAD helps find lobular carcinoma in situ lesions
2009 06 23 14 37 33 976 Second Opinion Am
Breast
The breast screening hullabaloo: Where are we today?
2010 07 29 11 11 10 875 Nomogram 250 V3
Breast
Tool predicts breast cancer recurrence risk for DCIS patients
2010 07 26 13 34 13 808 O Connell Conebeam Ct Breast Thumb
Breast
Study offers comparison of conebeam breast CT to mammo
More in Breast
MRI radiomics model predicts risk in women with DCIS
By Will Morton
An MRI-based radiomics model shows potential for distinguishing low- from high-risk cases of ductal carcinoma in situ (DCIS), an early form of breast cancer.
April 1, 2025
Dcis Thumbnail
Do radiologists trust mammography AI software?
By Erik L. Ridley
A large-scale prospective trial exploring the use of mammography AI software in a breast cancer screening program has found that recalls were lower when cases were flagged by AI.
March 18, 2025
Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.
Mammographic breast density not affected by multivitamins
By AuntMinnie.com staff writers
The use of multivitamin supplements has no influence on mammographic breast density, researchers have reported.
March 17, 2025
Breast Mammo 400
FES-PET shows promise staging patients with low-grade breast cancer
By Will Morton
F-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.
March 4, 2025
Fes Pet2 Thumbnail
Interventional breast radiology can boost sustainability efforts
By Amerigo Allegretto
Minimally invasive breast interventions can contribute to best sustainability practices, suggest presentations given at ECR 2025.
March 3, 2025
Breast Mammo
Breast ultrasound effective for screening women with dense tissue
By Kate Madden Yee
Ultrasound can play a significant role in cancer detection for women with dense breast tissue where access to supplemental screening with MRI and/or contrast mammography is limited, researchers have reported.
February 25, 2025
Breast Ultrasound
1 in 20 women around the world diagnosed with breast cancer
By Amerigo Allegretto
About one in 20 women globally are diagnosed with breast cancer and women living in low- to middle-income countries are at higher risk.
February 24, 2025
Breast Mammo
Women with BRCA1/2 germline mutations are often denied breast MRI
By Kate Madden Yee
Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.
January 3, 2025
Mri Breast Cancer
Study shows women will pay for AI breast cancer screening exam
By Liz Carey
Some clinical practices have elected to offer enhanced workflows enabled by AI, at an additional cost.
December 5, 2024
Abnormal mammogram (left) compared with normal mammogram. Image courtesy of the RSNA.
Sectra inks 5-year deal with MaineGeneral Health
By AuntMinnie.com staff writers
Sectra has secured a five-year agreement with MaineGeneral Health to use Sectra One Cloud and its modules for radiology and breast imaging.
October 15, 2024
Sectra Rsna 2019 400
New theranostics pairing tested in breast cancer patients
By Kate Madden Yee
A new theranostics pairing of molecular imaging and radioligand therapy shows promise as a treatment option for patients with metastatic breast cancer, researchers have found.
July 31, 2024
Breast Cancer
Black women less likely to undergo preoperative breast MRI
By Kate Madden Yee
Black women diagnosed with breast cancer are less likely than their white counterparts to undergo preoperative MRI, researchers report.
July 10, 2024
Mri Breast Cancer
Page 1 of 570
Next Page